- $820.80m
- $743.55m
- $162.02m
- 73
- 24
- 38
- 41
Annual balance sheet for Blend Labs, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-Q |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 152 | 547 | 354 | 137 | 94.2 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 22.1 | 39.4 | 24 | 19.9 | 17.2 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 186 | 613 | 396 | 170 | 135 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 17.3 | 20.9 | 17.4 | 12.5 | 12 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 216 | 1,112 | 433 | 206 | 178 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 35 | 60 | 35.5 | 31.6 | 39 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 52.4 | 338 | 310 | 225 | 92.8 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 163 | 775 | 123 | -19.2 | 85.3 |
| Total Liabilities & Shareholders' Equity | 216 | 1,112 | 433 | 206 | 178 |
| Total Common Shares Outstanding |